A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.

Suzannah J Rihn ORCID logo; AndresMerits; SiddharthBakshi; Matthew L Turnbull ORCID logo; Arthur Wickenhagen ORCID logo; Akira JT Alexander ORCID logo; CarlaBaillie; Benjamin Brennan ORCID logo; FionaBrown; KirstynBrunker; +72 more... Steven R Bryden ORCID logo; Kerry ABurness; StephenCarmichael; Sarah JCole; Vanessa MCowton; Paul Davies ORCID logo; ChrisDavis; Giuditta De Lorenzo ORCID logo; Claire L Donald ORCID logo; MarkDorward; James IDunlop; MatthewElliott; MazighFares; Ana da Silva Filipe ORCID logo; Joseph RFreitas; Wilhelm Furnon ORCID logo; Rommel J Gestuveo ORCID logo; AnnaGeyer; DanielGiesel; Daniel M Goldfarb ORCID logo; Nicola Goodman ORCID logo; RoryGunson; C James Hastie ORCID logo; Vanessa Herder ORCID logo; Joseph Hughes ORCID logo; ClareJohnson; Natasha Johnson ORCID logo; AlainKohl; KarenKerr; Hannah Leech ORCID logo; Laura SandraLello; KathyLi; Gauthier Lieber ORCID logo; XiangLiu; RajendraLingala; ColinLoney; Daniel Mair ORCID logo; Marion JMcElwee; StevenMcFarlane; Jenna Nichols ORCID logo; Kyriaki Nomikou ORCID logo; AnneOrr; Richard J Orton ORCID logo; MassimoPalmarini; Yasmin A Parr ORCID logo; Rute Maria Pinto ORCID logo; SamanthaRaggett; ElaineReid; David L Robertson ORCID logo; Jamie Royle ORCID logo; Natalia Cameron-Ruiz ORCID logo; James G Shepherd ORCID logo; Katherine Smollett ORCID logo; Douglas GStewart; Meredith Stewart ORCID logo; Elena Sugrue ORCID logo; Agnieszka MSzemiel; Aislynn Taggart ORCID logo; Emma C Thomson ORCID logo; Lily Tong ORCID logo; Leah STorrie; RachelToth; MargusVarjak; SainanWang; Stuart G Wilkinson ORCID logo; Paul GWyatt; EvaZusinaite; Dario RAlessi; Arvind H Patel ORCID logo; Ali Zaid ORCID logo; Sam J Wilson ORCID logo; Suresh Mahalingam ORCID logo; (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS biology, 19 (2). e3001091-. ISSN 1544-9173 DOI: 10.1371/journal.pbio.3001091
Copy

The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide pandemic causing substantial morbidity, mortality, and economic devastation. In response, many laboratories have redirected attention to SARS-CoV-2, meaning there is an urgent need for tools that can be used in laboratories unaccustomed to working with coronaviruses. Here we report a range of tools for SARS-CoV-2 research. First, we describe a facile single plasmid SARS-CoV-2 reverse genetics system that is simple to genetically manipulate and can be used to rescue infectious virus through transient transfection (without in vitro transcription or additional expression plasmids). The rescue system is accompanied by our panel of SARS-CoV-2 antibodies (against nearly every viral protein), SARS-CoV-2 clinical isolates, and SARS-CoV-2 permissive cell lines, which are all openly available to the scientific community. Using these tools, we demonstrate here that the controversial ORF10 protein is expressed in infected cells. Furthermore, we show that the promising repurposed antiviral activity of apilimod is dependent on TMPRSS2 expression. Altogether, our SARS-CoV-2 toolkit, which can be directly accessed via our website at https://mrcppu-covid.bio/, constitutes a resource with considerable potential to advance COVID-19 vaccine design, drug testing, and discovery science.



picture_as_pdf
journal.pbio.3001091.pdf
subject
Published Version
Available under Creative Commons: 3.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work associated with the research centre(s):

Find work from this publication: